Literature DB >> 1260779

Letter: Prevention by coenzyme Q10 (NSC-140865) of the inhibition by adriamycin (NSC-123127) of coenzyme Q10 enzymes.

T Kishi, K Folkers.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 1260779

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN： 0361-5960


× No keyword cloud information.
  5 in total

1.  Rescue by coenzyme Q10 from electrocardiographic abnormalities caused by the toxicity of adriamycin in the rat.

Authors:  K Folkers; J Y Choe; A B Combs
Journal:  Proc Natl Acad Sci U S A       Date:  1978-10       Impact factor: 11.205

2.  Cardiac disease induced by chronic adriamycin administration in dogs and an evaluation of vitamin E and selenium as cardioprotectants.

Authors:  J F Van Vleet; V J Ferrans; W E Weirich
Journal:  Am J Pathol       Date:  1980-04       Impact factor: 4.307

3.  Bioenergetics in clinical medicine: prevention by forms of coenzyme Q of the inhibition by adriamycin of coenzyme Q10-enzymes in mitochondria of the myocardium.

Authors:  T Kishi; T Watanabe; K Folkers
Journal:  Proc Natl Acad Sci U S A       Date:  1976-12       Impact factor: 11.205

Review 4.  Treatment-related cardiotoxicity in survivors of childhood cancer.

Authors:  Steven E Lipshultz; Thomas R Cochran; Vivian I Franco; Tracie L Miller
Journal:  Nat Rev Clin Oncol       Date:  2013-10-29       Impact factor: 66.675

Review 5.  Doxorubicin (adriamycin) cardiomyopathy.

Authors:  E Saltiel; W McGuire
Journal:  West J Med       Date:  1983-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.